MedTrace Logo

The Effects Of Low Insulinemic Index Diet On Overweight And Obese Patients With Polycystic Ovary Syndrome

NCT07124767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-08-15

No results posted yet for this study

Summary

The aim of this study was to investigate the relationship between PCOS and insulinemic index in overweight and/or obese women with PCOS and to evaluate potential beneficial effects on PCOS. In this study, overweight and obese women with PCOS were divided into two groups. The first group (n=15) received a 6-week nutritional program consisting of low insulin index foods as recommended by TÜBER, while the other group (n=15) received the healthy eating recommendations outlined in TÜBER. Differences in endocrine, metabolic, and anthropometric parameters between these two groups were examined after each 6-week dietary intervention.

Conditions

  • PCOS (Polycystic Ovary Syndrome)
  • Insulinemic Response

Interventions

OTHER

6 weeks of diet with low insulin index diet

6 weeks diet period for the low insulin index group. this group has a diet programme assigned by the conductor dietitian.

OTHER

6 weeks of dieting according to TÜBER nutrition recommendations

6 weeks of diet according to the TÜBER recomendations were applied to this group. Diets were assigned by the conductor dietitian.

Sponsors & Collaborators

  • Betül Gümüş

    lead OTHER

Principal Investigators

  • betül gümüş, masters · Atlas University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-28
Primary Completion
2025-05-20
Completion
2025-07-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07124767 on ClinicalTrials.gov